Stoke Therapeutics shares owned by Gilder, Gagnon, Howe & Co
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Gilder, Gagnon, Howe & Co
from 13F filings
Historical chart of Gilder, Gagnon, Howe & Co investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Gilder, Gagnon, Howe & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $327k | 62k | 5.26 |
| 2023-09-30 | $245k | 62k | 3.94 |
| 2023-06-30 | $543k | 51k | 10.63 |
| 2023-03-31 | $433k | 52k | 8.33 |
| 2022-12-31 | $209k | 23k | 9.23 |
| 2022-09-30 | $743k | 58k | 12.84 |
| 2022-06-30 | $770k | 58k | 13.21 |
| 2022-03-31 | $12M | 565k | 21.05 |
| 2021-12-31 | $26M | 1.1M | 23.99 |
| 2021-09-30 | $29M | 1.1M | 25.44 |
| 2021-06-30 | $42M | 1.2M | 33.66 |
| 2021-03-31 | $49M | 1.3M | 38.84 |
| 2020-12-31 | $91M | 1.5M | 61.93 |
| 2020-09-30 | $50M | 1.5M | 33.49 |
| 2020-06-30 | $37M | 1.6M | 23.83 |
| 2020-03-31 | $39M | 1.7M | 22.90 |
| 2019-12-31 | $52M | 1.8M | 28.32 |
| 2019-09-30 | $40M | 1.9M | 21.49 |
| 2019-06-30 | $54M | 1.9M | 29.17 |